Sangamo Therapeutics, Inc.SGMONASDAQ

Revenue (LTM)

$58M

-67.2% YoY

Net Income (LTM)

$-98M

+62.0% YoY

Free Cash Flow

$-67M

Revenue CAGR (5Y)

-10.8%

Marginsimproving

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	118	111↓6.3%	111↑0.5%	176↑58.3%	58↓67.2%
Gross Profit	-62	111↑277.2%	99↓10.4%	176↑77.7%	58↓67.2%
Operating Income	-130	-183↓41.5%	-201↓9.8%	-274↓36.1%	-104↑62.1%
Net Income	-121	-178↓47.3%	-192↓7.8%	-258↓34.1%	-98↑62.0%
EBITDA	-124	-166↓33.8%	-189↓14.2%	-97↑48.8%	-89↑8.0%
EPS Diluted	-0.90	-1.23↓36.7%	-1.25↓1.6%	-1.48↓18.4%	-0.49↑66.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	131	179↑36.2%	100↓43.8%	45↓55.0%	42↓7.3%
Total Current Assets	660	399↓39.6%	300↓24.7%	94↓68.6%	52↓45.2%
Total Assets	939	722↓23.1%	563↓22.1%	165↓70.6%	102↓38.5%
Total Current Liabilities	144	128↓10.9%	112↓12.6%	48↓57.3%	46↓4.0%
Total Liabilities	441	347↓21.4%	268↓22.8%	82↓69.2%	79↓4.3%
Total Equity	498	375↓24.7%	295↓21.4%	83↓71.9%	23↓72.5%
Total Debt	42	48↑14.2%	43↓10.3%	38↓11.6%	31↓19.8%
Net Debt	-89	-131↓46.6%	-57↑56.2%	-7↑87.6%	-11↓59.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	170	-233↓237.3%	-224↑4.1%	-225↓0.5%	-67↑70.1%
Capital Expenditure	-15	-23↓58.2%	-20↑13.3%	-21↓4.9%	-0↑98.7%
Free Cash Flow	155	-257↓265.3%	-244↑5.0%	-246↓0.9%	-67↑72.6%
Stock-Based Comp	26	33↑28.2%	32↓4.0%	27↓13.5%	12↓54.7%
Net Change in Cash	51	48↓6.6%	-78↓265.0%	-55↑29.6%	-3↑94.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance